eliglustat
Showing 1 - 6 of 6
Gaucher Disease, Type III Trial in Taipei (Eliglustat)
Completed
- Gaucher Disease, Type III
- Eliglustat
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 13, 2022
Solid Tumor, Hematologic Malignancy Trial in Beijing (Eliglustat, Immune checkpoint inhibitor)
Recruiting
- Solid Tumor
- Hematologic Malignancy
- Eliglustat
- Immune checkpoint inhibitor
-
Beijing, ChinaDepartment of Biotherapeutic, Chinese PLA General Hospital
Apr 28, 2022
Gaucher Disease Trial in Miami, St. Paul, Knoxville (eliglustat)
Completed
- Gaucher Disease
- eliglustat
-
Miami, Florida
- +2 more
Mar 7, 2017
Gaucher Disease Trial in Miami, Knoxville (eliglustat)
Completed
- Gaucher Disease
- eliglustat
-
Miami, Florida
- +1 more
Feb 9, 2017
Gaucher Disease Trial in Evansville (eliglustat)
Completed
- Gaucher Disease
- eliglustat
-
Evansville, IndianaInvestigational Site Number 840001
May 26, 2015